ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,26%
Bitcoin
66.969,00
2,65%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Innovate Biopharmaceuticals Inc (INNT)

  7. Innovate Biopharmaceuticals Inc (INNT) News

INNT

Innovate Biopharmaceutic... (INNT)

Innovate Biopharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:INNT
DatumZeitQuelleÜberschriftSymbolFirma
13/11/201914h00PR Newswire (US)RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Dise...NASDAQ:INNTInnovate Biopharmaceuticals Inc
08/11/201922h14Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:INNTInnovate Biopharmaceuticals Inc
07/11/201922h46Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INNTInnovate Biopharmaceuticals Inc
07/10/201913h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
28/08/201900h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
28/08/201900h40Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
13/08/201915h00GlobeNewswire Inc.Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac ...NASDAQ:INNTInnovate Biopharmaceuticals Inc
08/08/201922h43Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INNTInnovate Biopharmaceuticals Inc
08/08/201922h36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
08/08/201922h30GlobeNewswire Inc.Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate UpdatesNASDAQ:INNTInnovate Biopharmaceuticals Inc
15/07/201923h30GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings ReleaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
15/07/201912h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:INNTInnovate Biopharmaceuticals Inc
03/07/201923h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
03/07/201923h04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:INNTInnovate Biopharmaceuticals Inc
03/07/201923h03Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INNTInnovate Biopharmaceuticals Inc
01/07/201923h00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
27/06/201923h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
24/06/201913h00GlobeNewswire Inc.Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial OfficerNASDAQ:INNTInnovate Biopharmaceuticals Inc
10/06/201923h04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
10/06/201914h01GlobeNewswire Inc.Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac DiseaseNASDAQ:INNTInnovate Biopharmaceuticals Inc
05/06/201901h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
04/06/201923h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
04/06/201923h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
03/06/201914h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
31/05/201923h03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INNTInnovate Biopharmaceuticals Inc
31/05/201922h05Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:INNTInnovate Biopharmaceuticals Inc
28/05/201922h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
23/05/201914h45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INNTInnovate Biopharmaceuticals Inc
20/05/201915h45GlobeNewswire Inc.Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Lar...NASDAQ:INNTInnovate Biopharmaceuticals Inc
17/05/201922h54Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:INNTInnovate Biopharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INNT

Kürzlich von Ihnen besucht

NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AAPL
Apple
TG
RHM
Rheinmetall
FX
EURGBP
Euro vs Sterling
TG
ALV
Allianz
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
DBI
SDXP
SDAX
USOTC
DTEGY
Deutsche Telekom (QX)
CCOM
US30
US 30
COIN
SOLUSD
Solana
CCOM
SILVER
SILVER
CCOM
US100
US Tech 100
TG
432
Arbor Metals
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten